164 related articles for article (PubMed ID: 32639665)
1. Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming.
Wang X; Li N; Han A; Wang Y; Lin Z; Yang Y
Cancer Sci; 2020 Nov; 111(11):4061-4074. PubMed ID: 32639665
[TBL] [Abstract][Full Text] [Related]
2. Ezrin as a prognostic indicator regulates colon adenocarinoma progression through glycolysis.
Wang Y; Yang Y; Wang X; Jin T; Zhu G; Lin Z
J Gastroenterol Hepatol; 2021 Mar; 36(3):710-720. PubMed ID: 32710796
[TBL] [Abstract][Full Text] [Related]
3. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
4. MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming.
Zhang Z; Li TE; Chen M; Xu D; Zhu Y; Hu BY; Lin ZF; Pan JJ; Wang X; Wu C; Zheng Y; Lu L; Jia HL; Gao S; Dong QZ; Qin LX
Br J Cancer; 2020 Jan; 122(2):209-220. PubMed ID: 31819189
[TBL] [Abstract][Full Text] [Related]
5. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
6. [Timeless promotes the proliferation of hepatocellular carcinoma cell by reprogramming of glucose metabolism].
Zhang JS; Yuan P; Yan ZY; Lu R; Li B; Geng XE; Mu J; Zhang HX
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):499-505. PubMed ID: 30060357
[No Abstract] [Full Text] [Related]
7. Ezrin expression is altered in mice lymphatic metastatic hepatocellular carcinoma and subcellular fractions upon Annexin 7 modulation in-vitro.
Hago AM; Gamallat Y; Mahmoud SA; Huang Y; Zhang J; Mahmoud YK; Wang J; Wei Y; Wang L; Zhou S; Awsh MA; Yabasin IB; Tang J
Biomed Pharmacother; 2017 Jan; 85():209-217. PubMed ID: 27914826
[TBL] [Abstract][Full Text] [Related]
8. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract][Full Text] [Related]
10. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
Chen J; Zhu H; Liu Q; Ning D; Zhang Z; Zhang L; Mo J; Du P; Liu X; Song S; Fan Y; Liang H; Liu J; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Jun; 38(1):273. PubMed ID: 31228948
[TBL] [Abstract][Full Text] [Related]
11. Deregulated GATA6 modulates stem cell-like properties and metabolic phenotype in hepatocellular carcinoma.
Tan HW; Leung CO; Chan KK; Ho DW; Leung MS; Wong CM; Ng IO; Lo RC
Int J Cancer; 2019 Oct; 145(7):1860-1873. PubMed ID: 30834518
[TBL] [Abstract][Full Text] [Related]
12. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
[No Abstract] [Full Text] [Related]
13. MicroRNA-22 expression in hepatocellular carcinoma and its correlation with ezrin protein.
Zhou L; He J; Zhang Y
J Int Med Res; 2013 Aug; 41(4):1009-16. PubMed ID: 23766411
[TBL] [Abstract][Full Text] [Related]
14. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
Dou C; Mo H; Chen T; Liu J; Zeng Y; Li S; Guo C; Zhang C
Pathol Res Pract; 2021 Mar; 219():153345. PubMed ID: 33517164
[TBL] [Abstract][Full Text] [Related]
15. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
16. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
[TBL] [Abstract][Full Text] [Related]
17. RUFY3 promotes the progression of hepatocellular carcinoma through activating NF-κB-mediated epithelial-mesenchymal transition.
Zhang Y; Ni W; Qin L
Aging (Albany NY); 2021 Sep; 13(17):21283-21293. PubMed ID: 34510031
[TBL] [Abstract][Full Text] [Related]
18. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological significance of ezrin and SIX1 protein expression in alpha fetoprotein-negative hepatocellular carcinoma].
Kong J; Zhou X; Han L; Quan C; Cui X; Lin Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):236-9. PubMed ID: 26927385
[TBL] [Abstract][Full Text] [Related]
20. Co-Expression of Ezrin-CLIC5-Podocalyxin Is Associated with Migration and Invasiveness in Hepatocellular Carcinoma.
Flores-Téllez TN; Lopez TV; Vásquez Garzón VR; Villa-Treviño S
PLoS One; 2015; 10(7):e0131605. PubMed ID: 26135398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]